Skip to content

Intellicell Biosciences, Inc.

CIK 0001125280

← back to feed
Revenue (TTM)
$120K
−100.0% YoY Q3 Nov 2014
Net Income (TTM)
−$15.49M
+35.5% YoY Q3 Nov 2014
EPS Diluted (TTM)
−$0.05
+23.1% YoY Q3 Nov 2014
Gross Margin
89.3%
Q3 Nov 2014
Operating Margin
-4,635.5%
Q3 Nov 2014
Net Margin
-12,910.1%
Q3 Nov 2014
Free Cash Flow (TTM)
−$3.74M
Q3 Nov 2014
Cash
$48.08K
Q3 Nov 2014
Total Debt
—
Q3 Nov 2014
Shares Outstanding
7.89B sh
Q3 Nov 2014

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings